Herbalife (HLF) | Financial Analysis & Statements
Herbalife Ltd. Small-cap Consumer Defensive
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.3B
Gross Profit
994.7M
77.53%
Operating Income
99.8M
7.78%
Net Income
85.1M
6.63%
EPS (Diluted)
$0.81
Balance Sheet Metrics
Total Assets
2.8B
Total Liabilities
3.3B
Shareholders Equity
-509.4M
Cash Flow Metrics
Operating Cash Flow
90.5M
Free Cash Flow
79.8M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Herbalife Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.0B | 5.0B | 5.1B | 5.2B | 5.8B |
| Cost of Goods Sold | 1.1B | 1.1B | 1.2B | 1.2B | 1.2B |
| Gross Profit | 3.9B | 3.9B | 3.9B | 4.0B | 4.6B |
| Gross Margin % | 77.9% | 77.9% | 76.5% | 77.4% | 78.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 3.4B | 1.9B | 1.9B | 1.8B | 2.0B |
| Other Operating Expenses | -4.8M | 1.6B | 1.6B | 1.7B | 1.8B |
| Total Operating Expenses | 3.4B | 3.5B | 3.5B | 3.5B | 3.8B |
| Operating Income | 481.0M | 385.9M | 356.4M | 545.2M | 734.1M |
| Operating Margin % | 9.5% | 7.7% | 7.0% | 10.5% | 12.7% |
| Non-Operating Items | |||||
| Interest Income | 8.5M | 12.3M | 11.5M | 6.1M | 4.4M |
| Interest Expense | 214.4M | 218.3M | 165.9M | 139.3M | 153.1M |
| Other Non-Operating Income | - | -10.5M | 1.0M | 12.8M | -24.6M |
| Pre-tax Income | 275.1M | 169.4M | 203.0M | 424.8M | 560.8M |
| Income Tax | 47.3M | -84.9M | 60.8M | 103.5M | 113.6M |
| Effective Tax Rate % | 17.2% | -50.1% | 30.0% | 24.4% | 20.3% |
| Net Income | 227.8M | 254.3M | 142.2M | 321.3M | 447.2M |
| Net Margin % | 4.5% | 5.1% | 2.8% | 6.2% | 7.7% |
| Key Metrics | |||||
| EBITDA | 610.7M | 509.1M | 482.2M | 679.5M | 821.5M |
| EPS (Basic) | $2.22 | $2.53 | $1.44 | $3.26 | $4.22 |
| EPS (Diluted) | $2.20 | $2.50 | $1.42 | $3.23 | $4.13 |
| Basic Shares Outstanding | 102800000 | 100600000 | 99000000 | 98500000 | 105900000 |
| Diluted Shares Outstanding | 102800000 | 100600000 | 99000000 | 98500000 | 105900000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Herbalife Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 353.1M | 415.3M | 575.2M | 508.0M | 601.5M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 91.9M | 68.9M | 81.2M | 70.6M | 66.9M |
| Inventory | 511.7M | 475.4M | 505.2M | 580.7M | 575.7M |
| Other Current Assets | 188.0M | 184.1M | 237.7M | 196.8M | 187.7M |
| Total Current Assets | 1.1B | 1.1B | 1.4B | 1.4B | 1.4B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.4B | 1.4B | 1.4B | 1.4B | 1.3B |
| Goodwill | 516.1M | 487.7M | 504.8M | 502.1M | 508.1M |
| Intangible Assets | 315.1M | 312.3M | 314.0M | 315.7M | 317.3M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 609.6M | 538.5M | 308.4M | 273.6M | 313.2M |
| Total Non-Current Assets | 1.6B | 1.6B | 1.4B | 1.4B | 1.4B |
| Total Assets | 2.8B | 2.7B | 2.8B | 2.7B | 2.8B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 99.8M | 70.0M | 84.0M | 89.8M | 92.0M |
| Short-term Debt | 56.4M | 323.2M | 349.0M | 66.9M | 72.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | 334.1M | 343.4M | 343.3M | 363.2M |
| Total Current Liabilities | 1.0B | 1.2B | 1.3B | 976.6M | 1.1B |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.1B | 2.1B | 2.4B | 2.9B | 2.9B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 155.0M | 152.7M | 171.6M | 166.4M | 196.5M |
| Total Non-Current Liabilities | 2.3B | 2.3B | 2.6B | 3.0B | 3.1B |
| Total Liabilities | 3.3B | 3.5B | 3.9B | 4.0B | 4.2B |
| Equity | |||||
| Common Stock | 100.0K | 100.0K | 100.0K | 100.0K | 100.0K |
| Retained Earnings | -579.7M | -808.0M | -1.1B | -1.2B | -1.2B |
| Treasury Stock | - | - | - | 0 | 328.9M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | -509.4M | -801.1M | -1.1B | -1.3B | -1.4B |
| Key Metrics | |||||
| Total Debt | 2.2B | 2.5B | 2.8B | 2.9B | 3.0B |
| Working Capital | 131.8M | -86.7M | 121.7M | 379.5M | 351.4M |
Balance Sheet Composition
Herbalife Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 227.8M | 254.3M | 142.2M | 321.3M | 447.2M |
| Depreciation & Amortization | 121.2M | 121.4M | 113.3M | 115.4M | 107.6M |
| Stock-Based Compensation | 44.1M | 50.0M | 48.0M | 44.4M | 54.1M |
| Working Capital Changes | -48.5M | -10.6M | 61.5M | -110.7M | -169.0M |
| Operating Cash Flow | 293.6M | 205.3M | 337.8M | 330.2M | 441.9M |
| Investing Activities | |||||
| Capital Expenditures | -80.4M | -84.1M | -135.0M | -156.4M | -151.4M |
| Acquisitions | -25.5M | - | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -108.7M | -84.6M | -134.8M | -156.2M | -156.4M |
| Financing Activities | |||||
| Share Repurchases | -8.2M | -8.3M | -11.0M | -146.7M | -1.0B |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 724.8M | 2.2B | 215.2M | 841.7M | 600.0M |
| Debt Repayment | -1.0B | -2.5B | -353.9M | -956.7M | -984.2M |
| Financing Cash Flow | -295.5M | -335.3M | -222.7M | 299.5M | -728.6M |
| Free Cash Flow | 252.9M | 163.4M | 222.5M | 196.1M | 308.9M |
| Net Change in Cash | -110.6M | -214.6M | -19.7M | 473.5M | -443.1M |
Cash Flow Trend
Herbalife Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
7.49
Forward P/E
5.27
Price to Book
-3.29
Price to Sales
0.34
PEG Ratio
-0.14
Profitability Ratios
Profit Margin
4.53%
Operating Margin
8.33%
Return on Equity
-44.82%
Return on Assets
11.27%
Financial Health
Current Ratio
1.13
Debt to Equity
-4.29
Beta
0.96
Per Share Data
EPS (TTM)
$2.20
Book Value per Share
$-4.99
Revenue per Share
$49.00
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| HLF | 1.7B | 7.49 | -3.29 | -44.82% | 4.53% | -4.29 |
| Kellanova | 29.0B | 22.80 | 6.91 | 32.11% | 10.08% | 145.10 |
| Kraft Heinz | 26.0B | 13.01 | 0.62 | -12.84% | -23.44% | 52.10 |
| W.K. Kellogg | 2.0B | 67.65 | 5.75 | 8.81% | 1.15% | 249.57 |
| BellRing Brands | 1.9B | 11.09 | -3.78 | -47.63% | 7.89% | -2.39 |
| Flowers Foods | 1.9B | 21.72 | 1.39 | 6.18% | 1.60% | 111.01 |
Financial data is updated regularly. All figures are in the company's reporting currency.



